Non-typhoidal Salmonella: Difference between revisions

From IDWiki
Non-typhoidal Salmonella
(Created page with "{{DISPLAYTITLE:Non-typhoidal ''Salmonella''}} == Background == * Serotypes of Salmonella enterica that exclude Typhi and Paratyphi, which cause Enteric fever|typhoid f...")
 
Line 1: Line 1:
 
{{DISPLAYTITLE:Non-typhoidal ''Salmonella''}}
 
{{DISPLAYTITLE:Non-typhoidal ''Salmonella''}}
   
−
== Background ==
+
==Background==
   
−
* Serotypes of [[Salmonella enterica]] that exclude Typhi and Paratyphi, which cause [[Enteric fever|typhoid fever]]
+
*Serotypes of [[Salmonella enterica]] that exclude Typhi and Paratyphi, which cause [[Enteric fever|typhoid fever]]
   
−
=== Epidemiology ===
+
===Epidemiology===
   
−
* Numerous animal reservoirs
+
*Numerous animal reservoirs
−
* May be transmitted by animal products (especially eggs, poultry, undercooked ground meat, dairy, or contaminated fresh produce), contaminated water exposure, and contact with animals and their environment
+
*May be transmitted by animal products (especially eggs, poultry, undercooked ground meat, dairy, or contaminated fresh produce), contaminated water exposure, and contact with animals and their environment
   
−
== Clinical Manifestations ==
+
==Clinical Manifestations==
   
−
=== Gastroenteritis ===
+
===Gastroenteritis===
   
−
* One of the most common causes of foodborne illness
+
*One of the most common causes of foodborne illness
−
* Incubation period [[Usual incubation period::6 to 48 hours]] (range [[Incubation period range::up to 7 days]])
+
*Incubation period [[Usual incubation period::6 to 48 hours]] (range [[Incubation period range::up to 7 days]])
−
* Diarrhea, abdominal pain, nausea and vomiting, fevers and chillds
+
*Diarrhea, abdominal pain, nausea and vomiting, fevers and chillds
−
** Stools are usually loose but can be profuse and watery ("cholera-like") or small volume but with tenesmus ("dysentery-like")
+
**Stools are usually loose but can be profuse and watery ("cholera-like") or small volume but with tenesmus ("dysentery-like")
−
* May have headaches and myalgias
+
*May have headaches and myalgias
−
* Can mimic [[appendicitis]] (from [[mesenteric adenitis]]) and [[inflammatory bowel disease]]
+
*Can mimic [[appendicitis]] (from [[mesenteric adenitis]]) and [[inflammatory bowel disease]]
−
* Self-limited, lasting 3 to 7 days
+
*Self-limited, lasting 3 to 7 days
   
−
=== Extraintestinal Manifestations ===
+
===Extraintestinal Manifestations===
   
−
==== Bacteremia ====
+
====Bacteremia====
   
−
* Most common extraintestinal site, in up to 8% of cases of NTS gastroenteritis
+
*Most common extraintestinal site, in up to 8% of cases of NTS gastroenteritis
−
* More common in older patients >65 years, immunocompromised hosts, and patients with [[hemoglobinopathies]]
+
*More common in older patients >65 years, immunocompromised hosts, and patients with [[hemoglobinopathies]] (particularly [[sickle cell disease]])
   
−
==== Endovascular Infection ====
+
====Endovascular Infection====
   
−
* Can cause [[aortitis]], [[vascular graft infection]], and endocarditis
+
*Can cause [[aortitis]], [[vascular graft infection]], and endocarditis
−
* Complicates up to 25% of bacteremia
+
*Complicates up to 25% of bacteremia
−
* More common in people with atherosclerosis, aortic aneurysms, prosthetic vascular grafts, valvular heart disease, and prosthetic heart valves
+
*More common in people with atherosclerosis, aortic aneurysms, prosthetic vascular grafts, valvular heart disease, and prosthetic heart valves
−
* Endovascular infection can be predicted by a scoring system[[CiteRef::chen2012a]]
+
*Endovascular infection can be predicted by a scoring system[[CiteRef::chen2012a]]
−
** +1 point for each of: male gender, hypertension, coronary artery disease, and serogroup C1 infection
+
**+1 point for each of: male gender, hypertension, coronary artery disease, and serogroup C1 infection
−
** −1 point for each of: immunsuppression and malignancy
+
**−1 point for each of: immunsuppression and malignancy
−
** ≤1 is low-risk and ≥2 is high-risk, giving a sensitivity of 95% and specificity 45%
+
**≤1 is low-risk and ≥2 is high-risk, giving a sensitivity of 95% and specificity 45%
   
−
==== Bone and Joint Infection ====
+
====Bone and Joint Infection====
   
−
* Can cause [[osteomyelitis]], especially in [[sickle cell disease]], as well as [[septic arthritis]]
+
*Can cause [[osteomyelitis]], especially in [[sickle cell disease]], as well as [[septic arthritis]]
−
* Can also cause a [[reactive arthritis]] characterized by lower-limb [[acute arthritis]], [[urethritis]], and [[conjunctivitis]]
+
*Can also cause a [[reactive arthritis]] characterized by lower-limb [[acute arthritis]], [[urethritis]], and [[conjunctivitis]]
   
−
==== Genitourinary Infection ====
+
====Genitourinary Infection====
   
−
* Can rarely cause [[urinary tract infection]]
+
*Can rarely cause [[urinary tract infection]]
−
* May be secondary to [[bacteremia]]
+
*May be secondary to [[bacteremia]]
   
−
==== Meningitis ====
+
====Meningitis====
   
−
* More common in infants
+
*More common in infants
   
−
=== Asymptomatic Carriage ===
+
===Asymptomatic Carriage===
   
−
* Some people chronically shed bacteria in stool for >1 year
+
*Some people chronically shed bacteria in stool for >1 year
−
* Less than 1%
+
*Less than 1%
   
−
== Management ==
+
==Management==
   
−
* Gastroenteritis
+
*Gastroenteritis
−
** Mild to moderate gastroenteritis: rehydration and supportive care
+
**Mild to moderate gastroenteritis: rehydration and supportive care
−
** Severe gastroenteritis: antibiotics
+
**Severe gastroenteritis: antibiotics
−
** Other indications for antibiotics include: older age >50 years, prosthetic joints, valvular heart disease, prosthetic heart vales, endovascular stents, severe atherosclerosis, active malignancy, uremia, [[sickle cell disease]], severe joint disease, immunosuppression, advanced or untreated HIV, infants <3 months
+
**Other indications for antibiotics include: older age >50 years, prosthetic joints, valvular heart disease, prosthetic heart vales, endovascular stents, severe atherosclerosis, active malignancy, uremia, [[sickle cell disease]], severe joint disease, immunosuppression, advanced or untreated HIV, infants <3 months
−
** Options include [[ceftriaxone]] 1-2 g IV q24h, [[ciprofloxacin]] 500 mg PO bid, [[azithromycin]] 1000 mg PO on day 1 followed by 500 mg PO on days 2 to 7, and [[TMP-SMX]] SD 1 tablet PO bid
+
**Options include [[ceftriaxone]] 1-2 g IV q24h, [[ciprofloxacin]] 500 mg PO bid, [[azithromycin]] 1000 mg PO on day 1 followed by 500 mg PO on days 2 to 7, and [[TMP-SMX]] SD 1 tablet PO bid
−
** Duration depends on immune status and bacteremia
+
**Duration depends on immune status and bacteremia
−
*** Immunocompetent without bacteremia: 3 to 7 days
+
***Immunocompetent without bacteremia: 3 to 7 days
−
*** Immunocompetent with bacteremia alone: 7 to 14 days
+
***Immunocompetent with bacteremia alone: 7 to 14 days
−
*** Advanced HIV/AIDS: 2 to 6 weeks
+
***Advanced HIV/AIDS: 2 to 6 weeks
−
*** Other immunosuppressed host: 14 or more days
+
***Other immunosuppressed host: 14 or more days
−
* Bacteremia: [[ceftriaxone]] 2 g IV q24h for 7 to 14 days
+
*Bacteremia: [[ceftriaxone]] 2 g IV q24h for 7 to 14 days
−
** Alternatives include [[cefotaxime]] or high-dose [[ciprofloxacin]]
+
**Alternatives include [[cefotaxime]] or high-dose [[ciprofloxacin]]
−
* Vascular prosthesis infection: as for bacteremia, for 6 weeks
+
*Vascular prosthesis infection: as for bacteremia, for 6 weeks
−
** Either remove prosthesis or consider lifelong suppressive therapy
+
**Either remove prosthesis or consider lifelong suppressive therapy
−
* [[Osteomyelitis]]: as for bacteremia, for 4+ weeks
+
*[[Osteomyelitis]]: as for bacteremia, for 4+ weeks
−
* [[Septic arthritis]]: as for bacteremia, for 4 to 6 weeks
+
*[[Septic arthritis]]: as for bacteremia, for 4 to 6 weeks
−
* [[Endocarditis]]: as for bacteremia, for 6 weeks
+
*[[Endocarditis]]: as for bacteremia, for 6 weeks
−
* [[Urinary tract infection]]: intravenous therapy for 1 to 2 weeks followed by oral therapy to complete 6 weeks
+
*[[Urinary tract infection]]: intravenous therapy for 1 to 2 weeks followed by oral therapy to complete 6 weeks
−
** IV: [[ceftriaxone]], [[cefotaxime]], [[ciprofloxacin]] IV/PO
+
**IV: [[ceftriaxone]], [[cefotaxime]], [[ciprofloxacin]] IV/PO
−
** PO: [[ciprofloxacin]] or [[TMP-SMX]]
+
**PO: [[ciprofloxacin]] or [[TMP-SMX]]
−
* Asymptomatic carriage: no treatment, since it does not eradicate carriage but does promote resistance
+
*Asymptomatic carriage: no treatment, since it does not eradicate carriage but does promote resistance
−
** Encourage hand hygiene
+
**Encourage hand hygiene
   
 
[[Category:Gram-negative bacilli]]
 
[[Category:Gram-negative bacilli]]

Revision as of 21:58, 9 January 2021


Background

Epidemiology

  • Numerous animal reservoirs
  • May be transmitted by animal products (especially eggs, poultry, undercooked ground meat, dairy, or contaminated fresh produce), contaminated water exposure, and contact with animals and their environment

Clinical Manifestations

Gastroenteritis

  • One of the most common causes of foodborne illness
  • Incubation period 6 to 48 hours (range up to 7 days)
  • Diarrhea, abdominal pain, nausea and vomiting, fevers and chillds
    • Stools are usually loose but can be profuse and watery ("cholera-like") or small volume but with tenesmus ("dysentery-like")
  • May have headaches and myalgias
  • Can mimic appendicitis (from mesenteric adenitis) and inflammatory bowel disease
  • Self-limited, lasting 3 to 7 days

Extraintestinal Manifestations

Bacteremia

  • Most common extraintestinal site, in up to 8% of cases of NTS gastroenteritis
  • More common in older patients >65 years, immunocompromised hosts, and patients with hemoglobinopathies (particularly sickle cell disease)

Endovascular Infection

  • Can cause aortitis, vascular graft infection, and endocarditis
  • Complicates up to 25% of bacteremia
  • More common in people with atherosclerosis, aortic aneurysms, prosthetic vascular grafts, valvular heart disease, and prosthetic heart valves
  • Endovascular infection can be predicted by a scoring system1
    • +1 point for each of: male gender, hypertension, coronary artery disease, and serogroup C1 infection
    • −1 point for each of: immunsuppression and malignancy
    • ≤1 is low-risk and ≥2 is high-risk, giving a sensitivity of 95% and specificity 45%

Bone and Joint Infection

Genitourinary Infection

Meningitis

  • More common in infants

Asymptomatic Carriage

  • Some people chronically shed bacteria in stool for >1 year
  • Less than 1%

Management

  • Gastroenteritis
    • Mild to moderate gastroenteritis: rehydration and supportive care
    • Severe gastroenteritis: antibiotics
    • Other indications for antibiotics include: older age >50 years, prosthetic joints, valvular heart disease, prosthetic heart vales, endovascular stents, severe atherosclerosis, active malignancy, uremia, sickle cell disease, severe joint disease, immunosuppression, advanced or untreated HIV, infants <3 months
    • Options include ceftriaxone 1-2 g IV q24h, ciprofloxacin 500 mg PO bid, azithromycin 1000 mg PO on day 1 followed by 500 mg PO on days 2 to 7, and TMP-SMX SD 1 tablet PO bid
    • Duration depends on immune status and bacteremia
      • Immunocompetent without bacteremia: 3 to 7 days
      • Immunocompetent with bacteremia alone: 7 to 14 days
      • Advanced HIV/AIDS: 2 to 6 weeks
      • Other immunosuppressed host: 14 or more days
  • Bacteremia: ceftriaxone 2 g IV q24h for 7 to 14 days
  • Vascular prosthesis infection: as for bacteremia, for 6 weeks
    • Either remove prosthesis or consider lifelong suppressive therapy
  • Osteomyelitis: as for bacteremia, for 4+ weeks
  • Septic arthritis: as for bacteremia, for 4 to 6 weeks
  • Endocarditis: as for bacteremia, for 6 weeks
  • Urinary tract infection: intravenous therapy for 1 to 2 weeks followed by oral therapy to complete 6 weeks
  • Asymptomatic carriage: no treatment, since it does not eradicate carriage but does promote resistance
    • Encourage hand hygiene

References

  1. ^  P.-L. Chen, C.-C. Lee, C.-Y. Li, C.-M. Chang, H.-C. Lee, N.-Y. Lee, C.-J. Wu, H.-I. Shih, H.-J. Tang, W.-C. Ko. A Simple Scoring Algorithm Predicting Vascular Infections in Adults With Nontyphoid Salmonella Bacteremia. Clinical Infectious Diseases. 2012;55(2):194-200. doi:10.1093/cid/cis381.